The anxiety medication Xanax has been recalled nationwide after it was found that pills may not dissolve correctly in the body, potentially reducing their effectiveness.
The recall, initiated last month by manufacturer Viatris, applies to a single lot of Xanax XR 3mg strength tablets. The Food and Drug Administration (FDA) recently classified the recall as Class II, indicating that use of the affected product could lead to temporary or medically reversible adverse health consequences, though the probability of serious harm is remote.
A Viatris spokesperson stressed that patient safety is paramount and that no other batches of Xanax XR or generic alprazolam are impacted. The company has received no reports of adverse reactions from the recalled lot.
Xanax is a benzodiazepine used to treat anxiety disorders. It works by slowing down the central nervous system. Patients are advised not to take any action regarding the recall; wholesalers and pharmacies have been instructed on returns. For inquiries, Viatris customer relations can be contacted at (800) 796-9526 or customer.service@viatris.com.
